Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Host Cells for Producing Recombinant Proteins

Recombinant proteins are conventionally generated by transfecting the recombinant DNA into a host cell, following which the host cells are cultured and the transfected DNA transcribed and translated. Different host cells can be chosen for recombinant protein p

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Recombinant proteins are conventionally generated by transfecting the recombinant DNA into a host cell, following which the host cells are cultured and the transfected DNA transcribed and translated. Different host cells can be chosen for recombinant protein production, the choice of which depends on the type of protein that needs to be generated, its functional activity and requisite yield.

Mammalian systems

Mammalian systems are often used to express mammalian proteins, since they represent a physiologically relevant environment. This system is used for producing human antibodies, complex proteins, and other proteins that are used in cell-based assays.

Mammalian expression system can also be used for the transient or stable expression of proteins within cell lines. Transient expression can generate large quantities of proteins within one to two weeks, while cell lines with stable expression can be used over several experiments.

The transient expression systems use suspension cultures and have the capability to produce gram/litre yields. Also, mammalian systems have a higher level of native folding and post-translational modifications compared to other systems.

Insect expression systems

Insect cells are another option for generating recombinant proteins. Insect cells provide many advantages, the main benefit of which is that the system can be scaled up and adapted for large scale expression of proteins that are functionally similar to mammalian proteins.

Furthermore, insect expression systems can generate yields up to 500ug/L. However, disadvantages of the system include the lengthiness of the process and culture conditions that are more challenging in comparison with prokaryotic system.

The role of yeasts and filamentous fungi

Saccharomyces cerevisiae was the first yeast species that was used for the purpose of making recombinant proteins. This species, along with several other yeast species, secrete the newly produced recombinant protein in to the culture media. Yeast cells can also perform correct folding and post-translational modifications of mammalian proteins in contrast to the prokaryotic systems.

One disadvantage of this system is the difference in glycosylation of proteins expressed in yeast cells when compared to mammalian cells. Yeast systems may be used to generate proteins that do not require glycosylation. Insulin is one notable example, hence yeast systems have been extensively used to produce this protein.

Filamentous fungi have also been used to generate various kinds of recombinant proteins. Fungi can secrete up to 30g/L of protein. However, fungi also produce proteases which limits their use to generate recombinant proteins.

Bacterial systems

Bacteria can be cultured and grown easily and fairly quickly, making this system popular with researchers. Bacterial cells can also yield high levels of recombinant protein.

The main disadvantage of this system is the expression of non-functional proteins, as bacteria do not posses the internal machinery to achieve the folding or post-translational modifications of mammalian proteins. In some cases, these proteins can also become insoluble, consequently necessitating harsh denaturants and protein-refolding procedures to recover the recombinant proteins.

Cell-free expression systems

In cell-free systems, synthesis of the protein can be carried out in vitro using extracts of whole cells that are compatible with translation. These cell extracts contain all the molecules and enzymes that are needed to transcribe, translate, and post-translationally modify the recombinant protein.

With additional supplements of cofactors, proteins of interest can be formed in a matter of hours. However, this system may not be applicable for large scale production of recombinant proteins. Advantages of this system include that proteins can be synthesized without cell culturing; also, it is possible to express many proteins together.

Chemical protein synthesis

This method is used for synthesis of recombinant proteins that have unnatural amino acids or proteins that are toxic in nature. Although this method provides a way to generate pure proteins, the quantity of the product is limited. Also, the method can be expensive for longer chains of polypeptides.

Sources

Last Updated: Jun 10, 2023

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Collaboration has played a significant role in your research career. Can you highlight some of the most impactful collaborations you've had and how they have contributed to your research in axon biology?

A significant collaboration is with the Versus Arthritis Pain Center in Nottingham, in particular with Vicky Chapman and Gareth Hathway. Initially, my work wasn't focused on pain research, but joining forces with experts from this center led half of my lab's work to be directed towards pain-related projects. Another meaningful collaboration involves studying motor neuron diseases alongside Prof. Rob Layfield and Dr. Dan Scott. This collaboration allows us to leverage our expertise in RNA and neuron development and apply it to conditions like motor neuron disease.

Source: www.news-medical.net ↗
02Your early research focused on predicting molecular properties such as solubility using machine learning. What did that teach you about data-driven property prediction?

Data-driven models, such as Quantitative Structure Activity Relationships (QSAR), are incredibly attractive because they offer rapid methods for predicting molecular properties, including those that are difficult to access through fundamental chemical and physical theory. For new molecules, in related regions of chemical space to the training data, they can often be very accurate. The challenge is that they typically do not generalize across large diverse chemical and biological spaces. Therefore real care is needed when applying them to novel chemistry or biology. Some attempts to build more widely applicable QSAR models have been made in recent years, but most models in use today are still built for specific chemistries and properties owing to the scale and complexity of chemical space. When I started this work, especially for solubility predictions, the datasets were modest by today’s standards, often hundreds to a few thousand molecules. One of the first things that teaches you is to explore the data carefully, assess its quality and quantity, and only then move forward with modeling. The aim is to capture genuine relationships between numerical molecular descriptions and important target endpoints, but those relationships may be only locally generalizable. I also think the phrase “simple descriptors” is interesting. Some are simple, such as atom counts or bond counts, but others rely on detailed parameterization, group contributions, and graph-theoretical techniques. We still see these descriptors used today, sometimes alongside embeddings from graph neural networks or language models. The main lesson for me is that there is no single workflow. Each dataset, model, and end-use case needs careful thought.

Source: www.news-medical.net ↗
03What impact do events like Pittcon have on the communication and further development of your research?

I think it may be the best forum or venue for a large number of both academic and industrial scientists to interact and communicate. In addition, the students are there and it is the best opportunity for them to hear your work and for you to hear about what they are doing, as well.

Source: www.news-medical.net ↗
04How are Affimers Made?

Affimers stem from the drive to generate alternative methods of studying protein binding and function, which can complement information provided by antibodies. As a type of affinity reagent, affimers are biophysically stable scaffolds of proteins that can be reused. Affimers can be made from two scaffolds: Adhiron scaffolds and human stefin A scaffolds. The stefin A scaffold is engineered from human stefin A protein, whereas Adhiron is synthetic. The Adhiron synthetic protein was originally made from the sequence of cystatin, and is very thermally stable. The Adhiron and stefin A scaffolds are structurally related. To select an appropriate affimer, screening is done to find suitable reagents for the target protein. The chosen coding regions are then cloned into an expression vector in Escherichia coli, and the recombinant protein was purified over the course of a week. This allows for generation of high quality proteins for diverse applications.

Source: www.news-medical.net ↗
05How long does it take for vitamins to work?

Biologically, vitamins are absorbed within hours and have instant metabolic effects, such as antioxidants that protect cells or compounds that are building blocks for making hormones. But, many factors impact their efficiency and could keep your body from fully absorbing them. Absorption and effects depend on each individual and what combination of vitamins they take. Gender, age, digestive health, medical conditions, and diet all play a role. One helpful practice to detect deficiencies is to look for the symptoms deficiencies create. Then, look for improvement in your symptoms with supplement intake. You are unlikely to see or feel changes if you do not lack nutrients. If you are chronically tired or see signs of unhealthy nails, hair, or skin, supplements may help as these are indicators that you are lacking nutrients in your diet. If you are unsure, your doctor can order tests to check for deficiencies in your blood.

Source: www.medicinenet.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →